Literature DB >> 34761325

The relationship between the apparent diffusion coefficient and the Ki-67 proliferation index in intracranial solitary fibrous tumor/hemangiopericytoma.

Shenglin Li1,2,3,4, Qing Zhou1,2,3,4, Peng Zhang5, Shize Ma6, Caiqiang Xue1,2,3,4, Juan Deng1,2,3,4, Xianwang Liu1,2,3,4, Junlin Zhou7,8,9,10.   

Abstract

This study evaluated the value of the apparent diffusion coefficient (ADC) in distinguishing grade II and III intracranial solitary fibrous tumors/hemangiopericytomas and explored the correlation between ADC and Ki-67. The preoperative MRIs of 37 patients treated for solitary fibrous tumor/hemangiopericytoma (grade II, n = 15 and grade III, n = 22) in our hospital from 2011 to October 2020 were retrospectively analyzed. We compared the difference between the minimum, average, maximum, and relative ADCs based on tumor grade and examined the correlation between ADC and Ki-67. Receiver operating characteristic curve analysis was used to analyze the diagnostic efficiency of the ADC. There were significant differences in the average, minimum, and relative ADCs between grade II and III patients. The optimal cutoff value for the relative ADC value to differentiate grade II and III tumors was 0.998, which yielded an area under the curve of 0.879. The Ki-67 proliferation indexes of grade II and III tumors were significantly different, and the average (r =  - 0.427), minimum (r =  - 0.356), and relative (r =  - 0.529) ADCs were significantly negatively correlated with the Ki-67 proliferation index. ADC can be used to differentiate grade II and III intracranial solitary fibrous tumors/hemangiopericytomas. Our results can be used to formulate a personalized surgical treatment plan before surgery.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Apparent diffusion coefficient; Intracranial; Ki-67 proliferation index; MRI; Solitary fibrous tumor/hemangiopericytoma

Mesh:

Substances:

Year:  2021        PMID: 34761325     DOI: 10.1007/s10143-021-01687-y

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   2.800


  25 in total

Review 1.  Thirty-nine cases of intracranial hemangiopericytoma and anaplastic hemangiopericytoma: a retrospective review of MRI features and pathological findings.

Authors:  Jun-lin Zhou; Jian-li Liu; Jing Zhang; Ming Zhang
Journal:  Eur J Radiol       Date:  2012-05-31       Impact factor: 3.528

2.  Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients.

Authors:  Martin J Rutkowski; Brian J Jian; Orin Bloch; Cheng Chen; Michael E Sughrue; Tarik Tihan; Igor J Barani; Mitchel S Berger; Michael W McDermott; Andrew T Parsa
Journal:  Cancer       Date:  2011-08-11       Impact factor: 6.860

3.  MR imaging of intracranial hemangiopericytomas.

Authors:  N Mama; A Ben Abdallah; I Hasni; K Kadri; N Arifa; M Ladib; K Tlili-Graiess
Journal:  J Neuroradiol       Date:  2014-01-08       Impact factor: 3.447

4.  Intracranial hemangiopericytomas: MR and CT features.

Authors:  M V Chiechi; J G Smirniotopoulos; H Mena
Journal:  AJNR Am J Neuroradiol       Date:  1996-08       Impact factor: 3.825

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease.

Authors:  Tarini Ratneswaren; Florence Rosie Avila Hogg; Mathew Joseph Gallagher; Keyoumars Ashkan
Journal:  J Neurooncol       Date:  2018-03-17       Impact factor: 4.130

Review 7.  Intracranial hemangiopericytoma--our experience in 30 years: a series of 43 cases and review of the literature.

Authors:  Angelina Graziella Melone; Alessandro D'Elia; Francesca Santoro; Maurizio Salvati; Roberto Delfini; Giampaolo Cantore; Antonio Santoro
Journal:  World Neurosurg       Date:  2013-11-13       Impact factor: 2.104

8.  Primary intracranial haemangiopericytoma: comparison of survival outcomes and metastatic potential in WHO grade II and III variants.

Authors:  Omprakash Damodaran; Peter Robbins; Neville Knuckey; Michael Bynevelt; George Wong; Gabriel Lee
Journal:  J Clin Neurosci       Date:  2014-04-13       Impact factor: 1.961

9.  Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors.

Authors:  Juliann Chmielecki; Aimee M Crago; Mara Rosenberg; Rachael O'Connor; Sarah R Walker; Lauren Ambrogio; Daniel Auclair; Aaron McKenna; Michael C Heinrich; David A Frank; Matthew Meyerson
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

10.  Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.

Authors:  Stefan Schob; Jonas Meyer; Matthias Gawlitza; Clara Frydrychowicz; Wolf Müller; Matthias Preuss; Lionel Bure; Ulf Quäschling; Karl-Titus Hoffmann; Alexey Surov
Journal:  PLoS One       Date:  2016-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.